Showing results (631-640 of 716) with videos related to

Sort By:
Pageof 72
Neuro-Oncology|March 23, 2026
Recent progress and future directions to advance glioblastoma research: A consensus perspective from the 2024 Christopher Davidson ForumGavin P Dunn, Kenny K H Yu, Max O Krucoff, et al.
Journal of Applied Clinical Medical Physics|May 6, 2019
Characterization and validation of an intra-fraction motion management system for masked-based radiosurgeryNels C Knutson, Brad J Hawkins, Douglas Bollinger, et al.
Oncoimmunology|March 26, 2019
Detection of neoantigen-specific T cells following a personalized vaccine in a patient with glioblastomaTanner M Johanns, Christopher A Miller, Connor J Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 4, 2014
In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogeneGavin P Dunn, Hiu Wing Cheung, Pankaj K Agarwalla, et al.
Eye (London, England)|September 19, 2022
Geographic and socioeconomic access disparities to Phase 3 clinical trials in ophthalmology in the United StatesRebecca Russ Soares, Charles Huang, James Sharpe, et al.
Bioorganic & Medicinal Chemistry Letters|July 16, 2008
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptaseZachary K Sweeney, Sahaja Acharya, Andrew Briggs, et al.
Medrxiv : the Preprint Server for Health Sciences|September 2, 2025
IDH1-dependent m6A methylation defines transcriptomic heterogeneity in gliomaSyeda Maheen Batool, Hanna Lee, Koushik Muralidharan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 20, 2024
A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed GlioblastomaJiayi Huang, Jian L Campian, Todd A DeWees, et al.
Journal of Medicinal Chemistry|March 21, 2013
De novo fragment design: a medicinal chemistry approach to fragment-based lead generationFrancisco X Talamas, Gloria Ao-Ieong, Ken A Brameld, et al.
BMJ (Clinical Research Ed.)|July 7, 2009
Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort studyJohn H Kempen, Ebenezer Daniel, James P Dunn, et al.
Pageof 72